Found: 8
Select item for more details and to access through your institution.
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5227, doi. 10.1007/s10238-023-01205-y
- By:
- Publication type:
- Article
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45000-z
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
P-036: Implementation of IgH/k Next Generation Sequencing for Multiple Myeloma Minimal Residual Disease monitoring: advantages in patients' management during daily clinical practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S58, doi. 10.1016/S2152-2650(21)02170-4
- By:
- Publication type:
- Article
OAB-059: Towards a comprehensive multimodal minimal residual disease assessment in multiple myeloma: the role of circulating cell-free DNA to define the extent of disease spreading.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S37, doi. 10.1016/S2152-2650(21)02131-5
- By:
- Publication type:
- Article
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S4, doi. 10.1016/S2152-2650(21)02080-2
- By:
- Publication type:
- Article
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 8, p. 657, doi. 10.3390/cells13080657
- By:
- Publication type:
- Article
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1001048
- By:
- Publication type:
- Article